1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
I got the idea for this article while reading a Q&A with CNBC’s Jim Cramer in the Brunswick Review. A big chunk of the interview had to do with Cramer’s TV job and how he manages to remain...
According to top analysts on the Street, these five “Strong Buy” biotech stocks are primed for outsized growth in the next 12 months.
Biotechs often present intriguing, and potentially...
Investors can expect higher earnings and more generous dividends.
More Investing News »